05.08.2011 • News • Huntsman • Q2 2011 • sales and profits

Huntsman Q2 Adjusted Profit Up

Huntsman posted second-quarter net income attributable to the company of $114 million or $0.47 per share, flat with last year. Adjusted net income for the second quarter rose to $117 million or $0.48 per share from $75 million or $0.31 per share in the year-ago quarter.

Analysts polled by Thomson Reuters expected the company to earn $0.49 per share in the quarter. Analysts' estimates typically exclude special items.

Revenues were $2.93 billion versus $2.34 billion last year. The Street estimated revenues of $2.77 billion for the quarter.

 

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Top-Feature

most read